U.S. Industrial REITs Stock News

NYSE:OPY
NYSE:OPYCapital Markets

Is It Too Late To Consider Oppenheimer Holdings (OPY) After A 69% One-Year Rally?

Investors may be wondering whether Oppenheimer Holdings at around US$99 a share still offers value, or if most of the opportunity has already been priced in. The stock has been volatile recently, with an 11.3% pullback over the last 7 days alongside a 9.3% gain over 30 days, and returns of 36.8% year to date and 69.4% over the past year. Recent headlines around capital markets activity and trading conditions have kept investor attention on brokers and financial services stocks, including...
NasdaqGS:WFRD
NasdaqGS:WFRDEnergy Services

Is It Too Late To Consider Weatherford International (WFRD) After Its 152% One Year Surge?

If you are wondering whether Weatherford International at around US$108.61 is still offering value after its run, this breakdown will help you see what the current price really reflects. The stock has seen a 14.0% gain over the last 30 days and a 34.3% return year to date, while the 1 year return sits at 151.7% despite a 1.5% decline over the past week. Recent news around Weatherford International has focused on its position within the broader energy services sector and how investors are...
NasdaqGS:VRSN
NasdaqGS:VRSNIT

VeriSign (VRSN) Valuation Check After Strong Q1 Results New Guidance And Confirmed Dividend

Why VeriSign’s latest earnings, guidance and dividend matter for investors VeriSign (VRSN) has drawn fresh attention after reporting first quarter 2026 results alongside updated full year guidance and a Board approved cash dividend, giving investors several new data points to assess. See our latest analysis for VeriSign. The earnings beat, fresh 2026 guidance and the approved US$0.81 dividend have coincided with firmer sentiment, with a 30 day share price return of 6.13% and a 14.65% year to...
NasdaqCM:SAFX
NasdaqCM:SAFXOil and Gas

Assessing XCF Global (SAFX) Valuation After Reno Restart, Twain Forbearance Deal And New Business Combination

XCF Global (SAFX) has drawn fresh attention after a series of updates, including a Q1 2026 operational briefing, a business combination agreement, a forbearance deal with lender Twain, and a sector conference appearance. See our latest analysis for XCF Global. Recent updates around the Reno facility restart, the business combination agreement, and the Twain forbearance deal have coincided with a sharp shift in sentiment, with a 90 day share price return of 166.1% but a 3 year total...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Travere Therapeutics (TVTX) Heads Into Q1 2026 With Sharply Narrowed Trailing Losses Testing Bull Case

Q1 2026 earnings snapshot sets up margins story for Travere Therapeutics (TVTX) Travere Therapeutics (TVTX) heads into its Q1 2026 update with recent quarterly revenue of US$129.7 million in Q4 2025 and basic EPS of US$0.29 in Q3 2025 giving way to a loss of US$0.24 per share in Q4, alongside trailing 12 month revenue of US$490.7 million and a net loss of US$50.3 million. Over the past year, revenue has moved from US$233.2 million on a trailing 12 month basis in Q4 2024 to US$490.7 million in...
NYSE:SPB
NYSE:SPBHousehold Products

Spectrum Brands And Oaktree Deal Refocuses Value On Home And Personal Care

Spectrum Brands Holdings (NYSE:SPB) has entered into a partnership with Oaktree Capital Management focused on its Home and Personal Care business. The transaction brings new investment into the segment and marks another step in Spectrum Brands' plan to separate this business from the rest of the company. The move is intended to reshape how Spectrum Brands allocates resources across its portfolio and could influence how investors view the stock. At a share price of $82.38 and with a return...
NasdaqGM:KALV
NasdaqGM:KALVBiotechs

Chiesi Deal Shapes KalVista Shareholder Outlook And Valuation Potential

Chiesi Farmaceutici S.p.A. has entered into a definitive agreement to acquire KalVista Pharmaceuticals (NasdaqGM:KALV). The deal includes a tender offer followed by a merger process, with completion subject to specified closing conditions. Responsibility for EKTERLY®, a treatment for hereditary angioedema (HAE), is set to move from KalVista to Chiesi once the transaction is finalized. KalVista focuses on treatments for hereditary angioedema, and EKTERLY® is a key product in that portfolio...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

Sotera Health (SHC) Margin Improvement To 6.7% Tests Bullish Profitability Narrative

Sotera Health (SHC) has just opened Q1 2026 reporting with trailing numbers that show total revenue of about US$1.2b over the last 12 months and basic EPS of US$0.27, alongside year over year earnings growth of 75.8%. Over the past reported quarters, revenue has ranged from US$254.5 million in Q1 2025 to US$311.3 million in Q3 2025, while quarterly basic EPS moved from a loss of US$0.05 in Q1 2025 to US$0.17 in Q3 2025, illustrating improving profit conversion as trailing net margin sits at...
NYSE:EQH
NYSE:EQHDiversified Financial

Equitable Holdings (EQH) Earnings Volatility And TTM Loss Challenge Bullish Narratives

Equitable Holdings (EQH) has just reported its Q1 2026 results with recent quarterly revenue figures ranging from US$1.4 billion to US$4.6 billion and basic EPS swinging between a loss of US$4.47 and a profit of US$0.71. On a trailing 12 month basis, EPS was US$4.83 in Q4 2024 before moving to a loss of US$4.83 by Q4 2025. Over the past year, the company has seen revenue move between US$10.8 billion and US$15.1 billion on a trailing 12 month view and net income shift from a profit of US$1.2...
NasdaqGS:NTRS
NasdaqGS:NTRSCapital Markets

Northern Trust Apprenticeship Push Ties ServiceNow Platform Work To Valuation

Northern Trust (NasdaqGS:NTRS) has engaged ServiceNow partner Xchange to bring an apprentice-powered IT delivery model into its operations. The partnership introduces apprentices directly into live ServiceNow projects as part of Northern Trust’s enterprise platform work. This move reflects a tangible investment in next-generation technology talent and day to day platform execution. For a custodian bank and asset servicing company like Northern Trust, technology and operational resilience...
NYSE:WU
NYSE:WUDiversified Financial

Western Union Stablecoin Push Tests Valuation Ideas And Long Term Relevance

Western Union (NYSE:WU) has launched USDPT, a regulated U.S. dollar-backed stablecoin, on the Solana blockchain. The company has chosen Fireblocks as its infrastructure provider as it begins using blockchain for agent and treasury settlement. Initial deployment focuses on the Philippines and Bolivia, with plans to extend consumer-facing products to more than 40 countries. For investors watching Western Union at a share price of $9.12, the move into a regulated stablecoin signals a push...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Has The Surge In Arm Holdings (ARM) To US$208 Left Limited Upside?

Wondering whether Arm Holdings at US$208.84 is priced for perfection or still leaves room on the table? This article walks through what the current share price may be implying about the stock's value. The stock has recently logged a 3.5% return over 7 days, 40.4% over 30 days, 82.0% year to date and 68.2% over the last year. This has likely sharpened the focus on both growth potential and risk. Recent coverage has centred on Arm Holdings as a key player in semiconductors, with growing...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop Sales Slide Puts Gas Price Pressures And Valuation In Focus

Wingstop (NasdaqGS:WING) is reporting a rare quarterly sales decline. Management links the weaker sales to higher gas prices pressuring customer spending. The CEO is signaling that sales could shrink further if current cost pressures persist. Wingstop focuses on quick service chicken wings, an area that often leans on steady takeout and delivery traffic. Recent commentary from the company now centers on softer sales and tighter consumer budgets rather than store expansion or menu...
NYSE:VIK
NYSE:VIKHospitality

3 Stocks Estimated To Be 25.6% To 38.5% Below Intrinsic Value

The United States market has shown robust growth, with a 1.8% increase over the last week and a remarkable 30% rise in the past year, while earnings are projected to grow by 16% annually. In such an environment, identifying stocks that are significantly undervalued relative to their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
NYSE:ORC
NYSE:ORCMortgage REITs

Did Orchid Island Capital’s (ORC) Q1 Loss After Years of Buybacks Just Recast Its Investment Story?

In the first quarter of 2026, Orchid Island Capital, Inc. reported a US$19.96 million net loss, or US$0.11 basic loss per share from continuing operations, compared with a net profit in the prior-year period, and confirmed it had completed its long-running share repurchase program with 6,257,826 shares bought back for US$84.80 million since 2015. This shift from profit to loss, following years of buybacks that retired more than a quarter of the company’s shares, raises questions about how...
NYSE:ROK
NYSE:ROKElectrical

Rockwell Automation (ROK) Trailing 11.5% Net Margin Tests Bullish Profitability Narratives

Rockwell Automation Q2 2026 earnings snapshot Rockwell Automation (ROK) opened its Q2 2026 earnings season with Q1 fiscal 2026 revenue of US$2.1 billion and basic EPS of US$2.71. This provides a reference point for how investors may assess the current US$435.93 share price against recent performance. The company reported quarterly revenue of US$2.0 billion in Q2 2025, US$2.3 billion in Q4 2025, and US$2.1 billion in Q1 2026. Over the same periods, basic EPS was US$2.22 in Q2 2025, US$1.23 in...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Has The Market Overlooked Biogen (BIIB) After A 62% One Year Share Price Jump

If you are wondering whether Biogen's current share price lines up with its underlying value, the recent performance gives you plenty to think about. The stock closed at US$189.13 recently, with returns of 3.1% over 7 days, 6.6% over 30 days, 6.4% year to date and 61.9% over the past year. The 3 year and 5 year returns sit at 39.8% and 32.1% declines respectively. These moves come as Biogen stays in focus in the large cap biotech space, with ongoing attention on its pipeline and portfolio...
NYSE:HCI
NYSE:HCIInsurance

Is It Too Late To Consider HCI Group (HCI) After Its Recent Share Price Pullback?

Wondering if HCI Group at around US$154 per share still offers value, or if most of the opportunity is already priced in. The stock has been choppy recently, with a 2.1% decline over the last 7 days, a 1.1% gain over the last month, and returns of 6.2% over 1 year and very large gains over 3 and 5 years. Recent coverage around the stock has focused on its long run-up over the past few years and how sentiment has shifted as the year to date return stands at a 15.8% decline. Together, these...
NYSE:CNA
NYSE:CNAInsurance

CNA Financial (CNA) Q1 Combined Ratio Worsening Rekindles Underwriting Volatility Concerns

Q1 2026 results: earnings reset after a strong year CNA Financial (CNA) opened 2026 with Q1 revenue of US$3.7b and basic EPS of US$0.78 on net income of US$211m, setting a different tone from the higher quarterly earnings seen through 2025. Over the past year, revenue has ranged from US$3.6b to US$3.8b per quarter while basic EPS moved between US$0.08 and US$1.49, feeding into trailing 12 month EPS of US$4.48 and net income of US$1.2b as margins have shifted quarter to quarter. For investors,...
NYSE:DCI
NYSE:DCIMachinery

Donaldson Acquisition Of Facet Filtration Recasts Growth Story Beyond Industrial Markets

Donaldson Company (NYSE:DCI) has completed its acquisition of Facet Filtration. The deal expands Donaldson's reach into aerospace, defense, and power generation end markets. The acquisition broadens the Industrial Solutions segment and diversifies the company's revenue base. Donaldson Company, trading at $86.28, has seen its stock return 32.7% over the past year and 41.9% over three years, with a 47.3% return over five years. The completion of the Facet Filtration acquisition adds new...